Advanced search

Filters

Capitalization

Sector

Select all

Add a keyword

Announcement Date

Since

Until

150 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Australia's CSL reaffirms upbeat forecast; profit jumps	02-12	RE
CSL : Shareholder Meeting Document	23-08-14	PU
Domtar Corporation completed the acquisition of Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others.	23-02-28	CI
Transcript : CSL Limited, H1 2023 Earnings Call, Feb 14, 2023	23-02-13
Australia's CSL Says 1st Half Profit Steady at Constant Currency	23-02-13	DJ
Australian biotech CSL profit jumps on post-lockdown revival	23-02-13	RE
CSL Announces Next CEO & Managing Director	22-12-12	PR
CSL Limited Announces Chief Executive Officer Changes	22-12-12	CI
CSL Limited Announces Management Changes	22-12-12	CI
Australia's CSL Ltd names insider Paul McKenzie as CEO	22-12-12	RE
CSL Appoints Chief Operating Officer as CEO, MD From March 2023	22-12-12	DJ
U.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B	22-11-22	PR
Transcript : CSL Limited - Special Call	22-11-02
Australia's CSL raises annual profit forecast on Swiss acquisition	22-10-16	RE
Transcript : CSL Limited - Special Call	22-10-16
Transcript : CSL Limited - Shareholder/Analyst Call	22-10-11
CSL presents new research and development center in Marburg, Germany	22-09-14	AQ
CSL : Annual Report 2022	22-09-01	PU
CSL : Shareholder Meeting Document	22-08-29	PU
Transcript : CSL Limited, 2022 Earnings Call, Aug 17, 2022	22-08-16
Australia biotech giant CSL reports profit dip, flags cost spiral	22-08-16	RE
CSL : Announces Carbon Targets	22-08-16	PU
CSL Net Profit Falls, But Expects Growth For Coming Year	22-08-16	DJ
Transcript : UGI Corporation, Q3 2022 Earnings Call, Aug 04, 2022	22-08-04
Finalization of Vifor Pharma acquisition	22-08-02	BU
Domtar Corporation entered into an agreement to acquire Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others for $2.5 billion.	22-07-05	CI
Australia biotech firm CSL says plasma business hit by Omicron, but demand robust	22-02-15	RE
Transcript : CSL Limited, H1 2022 Earnings Call, Feb 16, 2022	22-02-15
CSL 1st Half Net Profit Falls as Immunoglobulin Sales Decline	22-02-15	DJ
CSL : Half Year Results Investor Presentation	22-02-15	PU
CSL : Half Year Results Announcement	22-02-15	PU
Transcript : CSL Limited, Vifor Pharma AG - M&A Call	21-12-14
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update	21-12-14	DJ
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update	21-12-14	DJ
CSL : SWISS TENDER OFFER TO ACQUIRE 100% OF VIFOR PHARMA LTD	21-12-14	PU
CSL : Investor Presentation CSL Swiss Tender Acquisition of Vifor	21-12-14	PU
Australia's CSL to buy Swiss drugmaker Vifor for $11.7 bln	21-12-14	RE
CSL in Talks to Buy Vifor Pharma	21-12-02	CI
Transcript : CSL Limited - Special Call	21-10-18
Transcript : CSL Limited - Shareholder/Analyst Call	21-10-11
CSL : Annual Report	21-09-02	PU
CSL's Plasma Collections on Track to Exceed Pre-Pandemic Levels, CEO Says	21-08-17	DJ
Transcript : CSL Limited, 2021 Earnings Call, Aug 18, 2021	21-08-17
CSL : Results Announcement	21-08-17	PU
CSL : Results Presentation	21-08-17	PU
CSL Fiscal Year Net Profit Rises, But Expects Decline in Fiscal Year 2022	21-08-17	DJ
Transcript : BTB Real Estate Investment Trust - Shareholder/Analyst Call	21-06-15
UGI Corporation : Announces Executive Appointments for its Global LPG Line of Business	21-05-18	BU
UniQure N : CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec	21-05-07	AQ
CSL : Behring Announces Agreement with uniQure	21-05-06	PU

No results for this search